Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

EMERGENT BIOSOLUTIONS INC.

(EBS)
  Report
Delayed Nyse  -  04:00:02 2023-01-31 pm EST
13.19 USD   +2.09%
01/26FDA identifies recall of Emergent's decontamination kits as most serious
RE
01/10U.S. FDA panel to review Emergent's OTC opioid overdose drug
RE
01/09Emergent BioSolutions Says Preliminary 2022 Revenue Seen Down About 38%; To Reduce Workforce by 5%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about EMERGENT BIOSOLUTIONS INC.
01/09Emergent BioSolutions Says Preliminary 2022 Revenue Seen Down About 38%; To Reduce Work..
MT
01/09Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic F..
GL
01/09Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic F..
AQ
01/09Emergent Biosolutions Inc. Announces Executive Changes
CI
01/06Emergent Biosolutions to Supply RSDL Kits to US Defense Department
MT
01/05Emergent Biosolutions Signs US Military Contract of Up to $379.6 Million to Supply Skin..
MT
01/05Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDLİ (Reac..
GL
01/05Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDLİ (Reac..
AQ
01/05Emergent BioSolutions Receives $379.6 Million Procurement Contract to Supply RSDLİ (Rea..
CI
2022Emergent BioSolutions Says US FDA Accepts, Grants Priority Review for Over-the-Counter ..
MT
2022Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental..
GL
2022Emergent BioSolutions Inc. Announces U.S. FDA Acceptance and Priority Review of Supplem..
CI
2022Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vacc..
GL
2022Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vacc..
GL
2022Emergent BioSolutions Inc.'s Equity Buyback announced on November 11, 2021, has expired..
CI
More most relevant news
All news about EMERGENT BIOSOLUTIONS INC.
01/26FDA identifies recall of Emergent's decontamination kits as most serious
RE
01/10U.S. FDA panel to review Emergent's OTC opioid overdose drug
RE
01/09Emergent BioSolutions Says Preliminary 2022 Revenue Seen Down About 38%; To Reduce Work..
MT
01/09Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic F..
GL
01/09Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic F..
AQ
01/09Emergent Biosolutions Inc. Announces Executive Changes
CI
01/09Emergent Biosolutions Inc. : Results of Operations and Financial Condition, Costs Associat..
AQ
01/06Emergent Biosolutions to Supply RSDL Kits to US Defense Department
MT
01/05Emergent Biosolutions Signs US Military Contract of Up to $379.6 Million to Supply Skin..
MT
01/05Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDLİ (Reac..
GL
More news
News in other languages on EMERGENT BIOSOLUTIONS INC.
01/09Emergent BioSolutions déclare que ses revenus préliminaires pour 2022 sont en baisse d'..
01/09Emergent Biosolutions Inc. annonce des changements de direction
01/06Emergent Biosolutions fournira des kits RSDL au ministère de la Défense des États-Unis
01/05Emergent Biosolutions signe un contrat militaire américain d'un montant maximal de 379,..
01/05Emergent BioSolutions reçoit un contrat d'approvisionnement de 379,6 millions de dollar..
2022Mise à jour sectorielle : Les actions du secteur de la santé son..
2022Emergent BioSolutions déclare que la FDA américaine accepte et accorde une revue priori..
2022Emergent BioSolutions Inc. annonce l'acceptation par la FDA américaine et l'examen prio..
2022Emergent Biosolutions : perte ajustée au 3e trimestre, baisse du c..
2022Emergent BioSolutions Inc. annonce ses résultats pour le troisième trimestre et les neu..
More news
Analyst Recommendations on EMERGENT BIOSOLUTIONS INC.
2022Chardan Cuts Price Target on Emergent Biosolutions to $55 From $65 on Slower Revenue, P..
MT
2022Cowen Trims Emergent Biosolutions Price Target to $29 From $30, Maintains Market Perfor..
MT
2022Wells Fargo Adjusts Emergent Biosolutions' Price Target to $38 from $46, Keeps Equalwei..
MT
2022Cantor Fitzgerald Cuts Emergent Biosolutions to Neutral From Overweight, Price Target t..
MT
2022JPMorgan Trims Price Target for Emergent Biosolutions to $57 From $58, Maintains Neutra..
MT
More recommendations
Press releases
01/09Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic F..
GL
01/09Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic F..
AQ
01/09Emergent Biosolutions Inc. : Results of Operations and Financial Condition, Costs Associat..
AQ
01/05Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDLİ (Reac..
GL
01/05Emergent Biosolutions Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
More press releases
Upcoming event on EMERGENT BIOSOLUTIONS INC.